The increased levels of complement cascade components were found in COVID-19 patients, such as C5b-9, C4d and MASP2 (Magro et al., 2020), indicating that NLRP3 inflammasome may be activated in COVID-19 patients in a complement cascade-dependent manner. Here, NLRP3 is linked to COVID-19.